2000 - 2019年中国癌症所致疾病负担
Burden of Disease Due to Cancer - China, 2000-2019.
作者信息
Fan Xueqi, Zhang Bin, He Yuan, Zhou Xiaolong, Zhang Yingying, Ma Li, Li Xudong, Wu Jing
机构信息
National Center for Chronic and Noncommunicable Disease Control and Prevention, CDC China, Beijing, China.
Inner Mongolia Medical University, Huhehot, Inner Mongolia Autonomous Region, China.
出版信息
China CDC Wkly. 2022 Apr 15;4(15):306-311. doi: 10.46234/ccdcw2022.036.
Abstract
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?: Cancer is a major global public health problem and the leading cause of death in China. China has a large population, and therefore has a significant proportion of the global burden of cancer.
WHAT IS ADDED BY THIS REPORT?: The age-standardized incidence of cancer has increased in China, while the cancer mortality rate has decreased. Compared with younger age groups, individuals over 70 have a greater burden of cancer. Digestive tract cancer and breast cancer should be targeted for prevention, treatment, and control.
WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICES?: To effectively reduce the burden of cancer, early screening of key populations and age groups should be strengthened, and targeted and precise prevention and control strategies should be adopted.
摘要
关于该主题已知的信息有哪些？：癌症是一个重大的全球公共卫生问题，也是中国的主要死因。中国人口众多，因此在全球癌症负担中占很大比例。
本报告新增了哪些内容？：中国癌症的年龄标准化发病率有所上升，而癌症死亡率有所下降。与较年轻年龄组相比，70岁以上人群的癌症负担更大。消化道癌症和乳腺癌应作为预防、治疗和控制的重点。
对公共卫生实践有哪些启示？：为有效减轻癌症负担，应加强对重点人群和年龄组的早期筛查，并采取针对性和精准的防控策略。
相似文献
1
Burden of Disease Due to Cancer - China, 2000-2019.2000 - 2019年中国癌症所致疾病负担
China CDC Wkly. 2022 Apr 15;4(15):306-311. doi: 10.46234/ccdcw2022.036.
2
[The disease burden of pancreatic cancer in China in 1990 and 2017].[1990年和2017年中国胰腺癌的疾病负担]
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Sep 10;40(9):1084-1088. doi: 10.3760/cma.j.issn.0254-6450.2019.09.012.
3
[Disease burden of liver cancer in China: an updated and integrated analysis on multi-data source evidence].《中国肝癌的疾病负担：基于多数据源证据的更新与综合分析》
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Nov 10;41(11):1848-1858. doi: 10.3760/cma.j.cn112338-20200306-00271.
4
Disease Burden of Pancreatic Cancer - China, 1990-2019.1990 - 2019年中国胰腺癌的疾病负担
China CDC Wkly. 2022 Jun 17;4(24):527-531. doi: 10.46234/ccdcw2022.056.
5
[Disease burden of breast cancer in women in China, 1990-2017].1990 - 2017年中国女性乳腺癌疾病负担
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Jul 10;42(7):1225-1230. doi: 10.3760/cma.j.cn112338-20200908-01139.
6
Burden of Prostate Cancer in China, 1990-2019: Findings From the 2019 Global Burden of Disease Study.中国前列腺癌负担，1990-2019 年：2019 年全球疾病负担研究结果。
Front Endocrinol (Lausanne). 2022 May 25;13:853623. doi: 10.3389/fendo.2022.853623. eCollection 2022.
8
The Incidence, Mortality, and DALYs Trends Associated with Esophageal Cancer - China, 1990-2019.1990 - 2019年中国食管癌的发病率、死亡率及伤残调整生命年趋势
China CDC Wkly. 2022 Oct 28;4(43):956-961. doi: 10.46234/ccdcw2022.006.
9
[Disease burden of colorectal cancer in China: any changes in recent years?].[中国结直肠癌的疾病负担：近年来有何变化？]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Oct 10;41(10):1633-1642. doi: 10.3760/cma.j.cn112338-20200306-00273.
10
Mortality by cause for eight regions of the world: Global Burden of Disease Study.世界八个地区按病因划分的死亡率：全球疾病负担研究
Lancet. 1997 May 3;349(9061):1269-76. doi: 10.1016/S0140-6736(96)07493-4.
引用本文的文献
1
Reported prevalence and risk factors of malignant tumors in the elderly population in China: a nationwide cross-sectional study.中国老年人群恶性肿瘤的报告患病率及危险因素：一项全国性横断面研究。
Aging Clin Exp Res. 2025 Jun 23;37(1):194. doi: 10.1007/s40520-025-03109-1.
2
The epidemiology, etiology, and future prophylactic options for cancers in Mainland China.中国大陆癌症的流行病学、病因学及未来预防方案
Front Oncol. 2025 May 28;15:1579378. doi: 10.3389/fonc.2025.1579378. eCollection 2025.
3
ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation.整合素α4（ITGA4）作为人类癌症潜在的预后和免疫治疗生物标志物及其在胃癌中的临床意义：一项整合分析与验证
Front Oncol. 2025 Feb 12;15:1513622. doi: 10.3389/fonc.2025.1513622. eCollection 2025.
4
Characteristics and outcomes of cancer patients admitted to intensive care units in cancer specialized hospitals in China.中国癌症专科医院重症监护病房癌症患者的特征和结局。
J Cancer Res Clin Oncol. 2024 Apr 20;150(4):205. doi: 10.1007/s00432-024-05727-0.
5
Distinct experiences and care needs of advanced cancer patients with good ECOG performance status: a qualitative phenomenological study.晚期癌症患者 ECOG 表现状态良好时的不同体验和护理需求：一项定性现象学研究。
BMC Palliat Care. 2024 Apr 17;23(1):102. doi: 10.1186/s12904-024-01425-3.
6
Sinus metastasis of lung adenocarcinoma: a case report.肺腺癌鼻窦转移：一例报告
Front Med (Lausanne). 2024 Jan 11;10:1323222. doi: 10.3389/fmed.2023.1323222. eCollection 2023.
7
Cancer statistics for young adults aged 20 to 49 years in China from 2000 to 2017: a population-based registry study.中国 2000 年至 2017 年 20 至 49 岁青年人癌症发病和死亡统计：基于人群的注册研究。
Sci China Life Sci. 2024 Apr;67(4):711-719. doi: 10.1007/s11427-023-2445-1. Epub 2023 Dec 19.
8
Prognostic model of kidney renal clear cell carcinoma using aging-related long noncoding RNA signatures identifies THBS1-IT1 as a potential prognostic biomarker for multiple cancers.利用与衰老相关的长非编码 RNA 特征的肾透明细胞肾细胞癌预后模型确定 THBS1-IT1 为多种癌症的潜在预后生物标志物。
Aging (Albany NY). 2023 Sep 13;15(17):8630-8663. doi: 10.18632/aging.204949.
9
Trends of Mortality in End-Stage Liver Disease - China, 2008-2020.2008 - 2020年中国终末期肝病的死亡率趋势
China CDC Wkly. 2023 Jul 28;5(30):657-663. doi: 10.46234/ccdcw2023.128.
10
Incidence and risk factors of cancers in acromegaly: a Chinese single-center retrospective study.肢端肥大症患者癌症的发病情况及相关危险因素：一项中国单中心回顾性研究。
Endocrine. 2023 Nov;82(2):368-378. doi: 10.1007/s12020-023-03447-y. Epub 2023 Jul 13.
本文引用的文献
1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations.室外空气污染与癌症：当前证据及公共卫生建议概述
CA Cancer J Clin. 2020 Aug 25. doi: 10.3322/caac.21632.
3
Colorectal cancer statistics, 2020.2020 年结直肠癌统计数据。
CA Cancer J Clin. 2020 May;70(3):145-164. doi: 10.3322/caac.21601. Epub 2020 Mar 5.
4
Incidence and disease burden of prostate cancer from 1990 to 2017: Results from the Global Burden of Disease Study 2017.1990 年至 2017 年前列腺癌的发病率和疾病负担：2017 年全球疾病负担研究结果。
Cancer. 2020 Jan 1;126(9):1969-1978. doi: 10.1002/cncr.32733. Epub 2020 Feb 3.
5
Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries.2003-2015 年期间中国癌症生存率变化：基于 17 个癌症登记处的汇总分析。
Lancet Glob Health. 2018 May;6(5):e555-e567. doi: 10.1016/S2214-109X(18)30127-X.
6
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
7
Indoor air pollution and risk of lung cancer among Chinese female non-smokers.室内空气污染与中国女性不吸烟者肺癌风险。
Cancer Causes Control. 2013 Mar;24(3):439-50. doi: 10.1007/s10552-012-0130-8. Epub 2013 Jan 12.
Zotero 插件